ERBB2 and breast carcinoma: Such innovations include the integration of distinct imaging features in various cancers with their molecular profiles: HER2-positive breast cancer, for instance, typically demonstrates increased vascularization and texture alterations on MRI that can be detected by ML and correlate with its underlying molecular changes [45].